These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2092968)

  • 1. Ergometry as a basis for judging the antihypertensive effect.
    Franz IW; Tönnesmann U; Erb D; Ketelhut R
    Drugs; 1990; 40 Suppl 4():54-7. PubMed ID: 2092968
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.
    Lafleche A; Gautier S; Topouchian J; Wilmet CS; Girerd X; Safar ME; Benetos A
    Clin Pharmacol Ther; 1998 Jul; 64(1):96-105. PubMed ID: 9695724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy of nilvadipine and nitrendipine on circadian blood pressure.
    Keck M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S43-9. PubMed ID: 1283188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined drug therapy is better: successfully protecting elderly hypertensive patients].
    Trenkwalder P
    MMW Fortschr Med; 2008 Jul; 150(28-31):48-9. PubMed ID: 19009707
    [No Abstract]   [Full Text] [Related]  

  • 5. Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial.
    Thijs L; Richart T; de Leeuw PW; Kuznetsova T; Grodzicki T; Kawecka-Jaszcz K; O'Brien E; Redón J; Birkenhäger WH; Fagard R; Staessen JA
    J Hypertens; 2010 Apr; 28(4):865-74. PubMed ID: 20051905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Doxazosin and nitrendipine. A double-blind comparative study in patients with mild to moderate hypertension].
    Nechwatal W
    Fortschr Med; 1987 Nov; 105(34):679-82. PubMed ID: 2962918
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
    Zannad F; Vaur L; Dutrey-Dupagne C; Genes N; Clerson P
    J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in the elderly. Its diagnosis in general practice and treatment with felodipine and metoprolol.
    Davis RH; Burton RH; Freeling P; Graham-Evans JN; Goves JR; Orne-Smith EA; Osborne CJ; Ward DE
    Drugs; 1987; 34 Suppl 3():149-50. PubMed ID: 3327675
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urapidil in primary arterial hypertension].
    Román O; Sudy E; Gac JC; Valenzuela MA
    Rev Med Chil; 1987 Jul; 115(7):648-54. PubMed ID: 3331026
    [No Abstract]   [Full Text] [Related]  

  • 10. Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action.
    Waeber B; Borges ET; Christeler P; Guillaume-Gentil M; Hollenstein U; Mannhart M
    Cardiology; 1992; 80 Suppl 1():46-53. PubMed ID: 1534715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do arterial effects of antihypertensive drugs depend on subject's serum cholesterol?
    Megnien JL; Simon A; Mikaberidze E; Denarie N; Chironi G; Barra J; Armentano R; Levenson J
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):520-8. PubMed ID: 11588522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive treatment and CHD in the elderly.
    Fink KS; Ellsworth A
    Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract]   [Full Text] [Related]  

  • 13. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
    Mroczek WJ; Fotiu S; Davidov ME; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):769-77. PubMed ID: 4217243
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive efficacy of urapidil versus hydrochlorothiazide alone in patients with mild to moderate essential hypertension and of their combination in nonresponders to monotherapy.
    Fariello R; Dal Palu C; Pessina A; Semplicini A; Pirrelli A; Vulpis V; Carretta R; Bellini G; Buoninconti R; Wurst W
    Drugs; 1990; 40 Suppl 4():60-2. PubMed ID: 2092970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antihypertensive effect of once-daily administration of nitrendipine. A placebo-controlled study using non-invasive automatic ambulatory 24-hour blood pressure determination].
    Wortmann A; Schmidt M; Bachmann K
    Schweiz Rundsch Med Prax; 1987 Apr; 76(17):469-72. PubMed ID: 3602766
    [No Abstract]   [Full Text] [Related]  

  • 16. Does urapidil attenuate the blood pressure response to tracheal intubation for general anaesthesia?
    Quéré JF; Ozier Y; Bringier J; Morot B; Bernard D; Pigot B; Conseiller C
    Drugs; 1990; 40 Suppl 4():80-1. PubMed ID: 2092977
    [No Abstract]   [Full Text] [Related]  

  • 17. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM; Heagerty A; Laeis P
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of urapidil in the treatment of arterial hypertension].
    Ol'binskaia LI; Vertkin AL; Gogin EE; Zadionchenko VS; Martynov AI; Martynov IV; Kolassa N; Man int Vel'd AI; Sidorenko BA; Belova EV
    Kardiologiia; 1992 Apr; 32(4):99-111. PubMed ID: 1357221
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of a new multifactorial antihypertensive on heart morphology and function in mild to moderate essential arterial hypertension.
    Genovesi-Ebert A; Marabotti C; Palombo C; Ghione S; Cattaneo G; Noseda A; Spinazzi A
    Eur Heart J; 1992 Jun; 13 Suppl A():45-8. PubMed ID: 1356776
    [No Abstract]   [Full Text] [Related]  

  • 20. Disparities in blood pressure control under various antihypertensive regimens.
    Schmieder RE; Bähr M; Langewitz W; Rüddel H; Schulte W
    J Hypertens Suppl; 1989 May; 7(3):S85-7. PubMed ID: 2547917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.